Effectiveness and tolerability of administration of granulocyte colony-stimulating factor on left ventricular function in patients with myocardial infarction: A meta-analysis of randomized controlled trials

Clinical Therapeutics

Volumn 29, Issue 11, 2007, Pages 2406-2418

  Kang, Sheng ^a   Yang, Yuejin ^a   Li, Chong Jian ^a   Gao, Runlin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

granulocyte colony stimulating factor; left ventricular ejection fraction; meta analysis; randomized controlled trials

Indexed keywords

ACETYLSALICYLIC ACID; AMINOTRANSFERASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CREATINE KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO;

ARTICLE; BONE PAIN; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DEMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; EMBASE; FATIGUE; FEVER; FOLLOW UP; GENETIC HETEROGENEITY; HEADACHE; HEART DEATH; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL READMISSION; HUMAN; INJECTION SITE WARMTH; MEDLINE; META ANALYSIS; MUSCLE DISEASE; NAUSEA; PREVALENCE; QUALITY CONTROL; RASH; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; SCISEARCH; SIDE EFFECT; ST SEGMENT ELEVATION; STATISTICAL SIGNIFICANCE; STROKE; SYSTEMATIC REVIEW; TREATMENT DURATION;

ALGORITHMS; CARDIOVASCULAR DISEASES; DATA INTERPRETATION, STATISTICAL; ENDPOINT DETERMINATION; FEMALE; GRANULOCYTE COLONY STIMULATING FACTOR, RECOMBINANT; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 37449029136     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.11.008     Document Type: Article

References (36)

1. Pfeffer M., and Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81 (1990) 1161-1172
2. Anderlini P., Donato M., Chan K., et al. AIIogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: The M.D Anderson Cancer Center experience. Transfusion 39 (1999) 555-560
3. Flomenberg N., DiPersio J., and Calandra G. Role of CXCR4 chemokine receptor blockade using AM D3100 for mobilization of autologous hematopoietic progenitor cells. Ad:a Haematol 114 (2005) 198-205
4. Kajstura J., Rota M., Whang B., et al. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96 (2005) 127-137
5. Leri A., Kajstura J., and Anversa P. Cardiac stem cells and mechanisms of myocardial regeneration. Physiol Rev 85 (2005) 1373-1416
6. Kawamoto A., Murayama T., Kusano K., et al. Synergistic effect of bone marrow mobilization and vascular endothelial growth factor-2 gene therapy in myocardial ischemia. Circulation 110 (2004) 1398-1405
7. Kocher A., Schuster M., Szabolcs M., et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
8. Harada M., Qin Y., Takano H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nat Med 11 (2005) 305-311
9. Valgimigli M., Rigolin G., Cittanti C., et al. Use of granulocyte colony stimulating factor during acute myocardial infarction to enhance bone marrow stem cell mobilization in humans: Clinical and angiographic safety profile. Eur HeartJ 26 (2005) 1838-1845
10. Ince H., Petzsch M., Kleine H., et al. Prevention of leff ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: Final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial. Circulation 112 Suppl 9 (2005) 173-180
11. Kang H., Lee H., Na S., et al. Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: The MAGIC CelI-3-DES randomized, controlled trial. Circulation 114 Suppl 1 (2006) 1145-1151
12. Jadad A., Moore R., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Control Clin Trials 17 (1996) 1-12
13. Hristov M., Heussen N., Schober A., and Weber C. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: A metaanalysis. J Cell Mol Med 10 (2006) 727-733
14. Begg C., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
15. Egger M., Davey Smith G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
16. Ripa R., Jorgensen E., Wang Y., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: Result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
17. Suzuki K., Nagashima K., Arai M., et al. Effect of granulocyte colony stimulating factor treatment at a low dose but for a long duration in patients with coronary heart disease. CircJ 70 (2006) 430-437
18. Ince H., Petzsch M., Kleine H., et al. Preservation from left ventricular remodeling by front-integrated revascularization and stem cell liberation in evolving acute myocardial infarction by use of granulocyte-colony-stimulating factor (FIRSTLINE-AMI). Circulation 112 (2005) 3097-3106
19. Nienaber C., Petzsch M., Kleine H., et al. Effects of granulocyte-colony-stimulating factor on mobilization of bone-marrow-derived stem cells after myocardial infarction in humans. Nat Clin Pract Cardiovasc Med 3 Suppl 1 (2006) $73-$77
20. Kang H., Kim H., Zhang S., et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell random- ised clinical trial. Lancet 363 (2004) 751-756
21. Ellis S., Penn M., Bolwell B., et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: Results of a pilot dose-escalation randomized trial. Am Heart J 152 (2006) 1051
22. Ellis S., Penn M., Bolwell B., et al. Granulocyte colony stimulating factor in patients with large acute myocardial infarction: Results of a pilot dose-escalation randomized trial. Am Heart J 152 (2006) e9-e14
23. Kang H., Kim H., Koo B., et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-Year follow-up results of the Myocardial Regeneration and Anglogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 153 (2007) 237
24. Kang H., Kim H., Koo B., et al. Intracoronary infusion of the mobilized peripheral blood stem cell by G-CSF is better than mobilization alone by G-CSF for improvement of cardiac function and remodeling: 2-Year follow-up results of the Myocardial Regeneration and Anglogenesis in Myocardial Infarction with G-CSF and Intra-Coronary Stem Cell Infusion (MAGIC Cell) 1 trial. Am Heart J 153 (2007) e1-e8
25. Zohlnhofer D., Ott I., Mehilli J., et al., for the REVIVAL-2 Investigators. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: A randomized controlled trial. JAMA 295 (2006) 1003-1010
26. Deng Z., Yang C., Deng H., et al. Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction. Int J Cardiol 113 (2006) 92-96
27. Engelmann M., Theiss H., Hennig-Theiss C., et al. Autologous bone marrow stem cell mobilization induced by granulocyte colony-stimulating factor after subacute ST-segment elevation myocardial infarction undergoing late revascularization: Final results from the G-CSF-STEMI (Granulocyte Colony- Stimulating Factor ST-Segment Elevation Myocardial Infarction) trial J Am Coll. Cardiol 48 (2006) 1712-1721
28. Takano H., Hasegawa H., Kuwabara Y., et al. Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction. IntJ Cardiol 122 (2007) 41-47
29. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
30. de la Rubia J., Arbona C., de Arriba F., et al., for the Spanish Group of AIIogeneic Peripheral Blood Stem Cell Transplantation. Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion 42 (2002) 4-9
31. Carion A., Domenech J., Herault O., et al. Decreased stroma adhesion capaciW of CD34+ progenitor cells from mobilized peripheral blood is not lineage or stage-specific and is associated with low beta 1 and beta 2 integrin expression. J Hematother Stem Ceil Res 11 (2002) 491-500
32. Harada M., Qin Y., Takano H., et al. G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in car diomyocytes. Nat Med 11 (2005) 305-311
33. Dlubek D., Drabczak-Skrzypek D., and Lange A. Low CXCR4 membrane expression on CD34(+) cells characterizes cells mobilized to blood. Bone Marrow Transplant 37 (2006) 19-23
34. Hill J., Syed M., Arai A., et al. Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery disease. J Am Coil Cardiol 46 (2005) 1643-1648
35. Maekawa Y., Anzai T., Yoshikawa T., et al. Effect ofgranulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1510-1520
36. Zbinden S., Zbinden R., Meier P., et al. Safety and efficacy of subcutaneous only granulocyte-macrophage colony-stimulating factor for collateral growth promotion in patients with coronary artery disease. J Am Coil Cardiol 46 (2005) 1636-1642